Cisplatin News and Research

RSS
Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Study: Erlotinib improves progression-free survival in EGFR mutated NSCLC

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

Finding which chemotherapy regimen is associated with best outcomes for patients with bladder cancer

HKBU chemists discover metal-based inhibitor to treat triple-negative breast cancer

HKBU chemists discover metal-based inhibitor to treat triple-negative breast cancer

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Study reveals role of RUNX proteins in DNA repair

Study reveals role of RUNX proteins in DNA repair

Clinical study suggests new treatment direction for head and neck cancer in heavy smokers

Clinical study suggests new treatment direction for head and neck cancer in heavy smokers

New drug delivery system delivers anticancer drugs that reduce tumor size

New drug delivery system delivers anticancer drugs that reduce tumor size

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Study uncovers new protein complex that shields broken DNA ends

Study uncovers new protein complex that shields broken DNA ends

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Pediatric neuroblastoma patients have high risk of long-term psychological impairment

Pediatric neuroblastoma patients have high risk of long-term psychological impairment

Colorado researchers suggest new combination therapy for advanced head and neck cancer

Colorado researchers suggest new combination therapy for advanced head and neck cancer

International researchers succeed in stopping growth of mesothelioma in model animals

International researchers succeed in stopping growth of mesothelioma in model animals

Studies show hemp's potential for treating ovarian cancer

Studies show hemp's potential for treating ovarian cancer

Scientists discover new family of promising silver-based anti-cancer drugs

Scientists discover new family of promising silver-based anti-cancer drugs

Treating metastatic breast cancer with immunotherapy

Treating metastatic breast cancer with immunotherapy

Potential new principle for treatment of multiple forms of cancer

Potential new principle for treatment of multiple forms of cancer

Light-activated cancer drugs without toxic side effects are closer to becoming reality

Light-activated cancer drugs without toxic side effects are closer to becoming reality